首页   按字顺浏览 期刊浏览 卷期浏览 Therapeutic Trial of Interferon‐&ggr; in Patients with Epidemic Kaposi's Sarcoma
Therapeutic Trial of Interferon‐&ggr; in Patients with Epidemic Kaposi's Sarcoma

 

作者: Robert Krigel,   Chrystia Odajnyk,   Linda Laubenstein,   Richard Ostreicher,   James Wernz,   Jan Vilček,   Pablo Rubinstein,   Alvin Friedman‐Kien,  

 

期刊: Journal of Biological Response Modifiers  (OVID Available online 1985)
卷期: Volume 4, issue 4  

页码: 358-364

 

ISSN:0732-6580

 

年代: 1985

 

出版商: OVID

 

关键词: Acquired immune deficiency syndrome;Biologic response modifier;Epidemic Kaposi's sarcoma;Interferon;Interferon‐&ggr;.

 

数据来源: OVID

 

摘要:

Summary:An epidemic form of Kaposi's sarcoma associated with the acquired immune deficiency syndrome has been recently described. Seven homosexual men with biopsy‐documented epidemic Kaposi's sarcoma were treated with a human interferon‐&ggr; preparation. All patients had generalized disease. Only one patient had received prior chemotherapy, and one other patient had recovered from a prior opportunistic infection. Interferon‐&ggr; was administered in a dose of 500,000 U intramuscularly daily, with two 10‐day induction courses, separated by a 2‐week medication‐free period. This was followed by maintenance therapy in the same dose twice weekly. Toxicities consisted of a flu‐like illness with high fevers, shaking chills, myalgias, and arthralgias. There were no complete or partial responses. All patients exhibited disease progression, with a rapid progression of previously stable disease necessitating discontinuation of therapy in three patients. We conclude that low doses of this human interferon‐&ggr; preparation are ineffective in epidemic Kaposi's sarcoma.

 

点击下载:  PDF (3069KB)



返 回